Drug pricing and affordability continue to be key issues at both the state and federal levels as new legislation is considered and implementation of legislation that has already passed is underway.
This past week, CBSA’s President & CEO Elyse Blazevich represented the Colorado life sciences community in Washington, D.C. at the 2023 We Work For Health Healthcare Summit, where she discussed issues that impact health innovation and patient access to life-changing and life-saving medicines with the Colorado Congressional Delegation, policy leaders, and life sciences leaders from across the country. The summit featured panels on 340B, PBMs, and the impacts of the Inflation Reduction Act.
In her meetings with the Colorado Congressional Delegation, Elyse emphasized CBSA’s perspectives on issues vital to our community. Those issues included:
- Support for the broadening bipartisan discussion on pharmacy benefit manager (PBM) reforms, such as the Patients…
Click here to view original post
